Medical treatment for cholangiocarcinoma-Reference-Cited by-同舟云学术

Medical treatment for cholangiocarcinoma

Published:2019-05 Issue:S1 Volume:39 Page:123-142
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Adeva Jorge¹^ORCID,Sangro Bruno²,Salati Maximiliano³⁴,Edeline Julien⁵^ORCID,La Casta Adelaida⁶,Bittoni Alessandro⁷,Berardi Rossana⁷,Bruix Jordi⁸,Valle Juan W⁹¹⁰

Affiliation:

1. Department of Medical Oncology Hospital Universitario 12 de Octubre Madrid Spain

2. Liver Unit and HPB Oncology Area Clinica Universidad de Navarra‐IDISNA and CIBEREHD Pamplona Spain

3. Department of Oncology University Hospital of Modena and Reggio Emilia Modena Italy

4. Division of Molecular Pathology Institute of Cancer Research and Gastrointestinal Unit Royal Marsden Hospital London and Sutton UK

5. Department of Medical Oncology Centre Eugene Marquis Rennes France

6. Department of Medical Oncology Hospital Universitario Donostia Navarra Spain

7. Clinica Oncologica Università Politecnica delle Marche Ospedali Riuniti Ancona Italy

8. Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit Hospital Clinic Barcelona Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) Barcelona Spain

9. Division of Cancer Sciences University of Manchester Manchester UK

10. Department of Medical Oncology The Christie NHS Foundation Trust Manchester UK

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14100

Reference156 articles.

1. The Global Burden of Cancer 2013

2. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: Operative results and long-term outcome

3. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer